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BACKGROUND: It has not been well understood whether the quality and quantity of protein intake could affect the quality of life. Quality of life is 
associated with nutritional status, but the usage of prognostic 
nutritional index (PNI) to reflect quality of life of head and 
neck cancer patients undergoing radiotherapy also still has 
not been widely studied.
METHODS: A cross sectional study was performed in 61 
head and neck cancer patient undergoing radiotherapy. The 
quantity and quality of protein intake were obtained using 
semiquantitative food frequency questionnaire (FFQ) which 
was analized by analyzed using Nutrisurvey 2007, PNI was 
obtained using a calculation of Onodera’s formula based 
on laboratory data of serum albumin and total lymphocyte 
count (TLC), and domains of quality of life were obtained 
from the interview of  European Organization for Research 
and Treatment of Cancer (EORTC) Quality of Life Core 
Questionnaire (QLQ-C30) and EORTC Quality of Life 
Head and Neck module (QLQ-H&N35) and then calculated 
to get each domain’s score on quality of life. 
RESULTS: Patient’s median of total protein intake was 1.42 
(0.26-4.11) g/kg/day. The median of PNI was 45.9 (29.4-
54.2). Quantity of protein intake was significantly correlated 
with several symptoms domain of quality of life. PNI was 
also significantly correlated with one functional domain and 
two symptom domains of quality of life. This study did not 
show a significant correlation between quantity and quality 
of protein intake with PNI.
CONCLUSION: PNI has the potential to reflect quality of 
life of head and neck cancer patients. Future studies might 
be  beneficial  to  show  the  usage  of  PNI  to  reflect  quality 
of life, especially involving the progressivity of quality of 
life. 
KEywORDS: animal protein, chemoradiotherapy, 
cachexia, quality of life
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Abstract
Introduction
Head and neck cancer remains as the sixth most common 
cancer worldwide, and is contributed to 350,000 of death per 
year.(1,2) It likely causes problems in speaking, breathing 
and eating process for the patients, thus would potentially 
impair their quality of life.(3-5)
 Most cancer patients suffered from a multiple array 
of inflammation-based syndromes, which also called cancer 
cachexia, that caused malnutrition by increasing proteolysis, 
lipolysis and inducing anorexia.(6) The difficulties in eating 
contributes to the reduction of calorie and protein intake, 
that will further worsen the problem related to the nutritional 
status and therapy that cancer patients already had.(5) 
 Radiotherapy is the most recommended treatment 
for advanced head and neck cancer, as it provides better 
locoregional control. The concurrent usage of chemotherapy 
would increase the effectiveness of radiotherapy by 
disrupting the cancer cell’s repair processes and inducing a 
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cell cycle arrest, thus adds better rate of successful treatment.
(7,8) Unfortunately, chemotherapy increases a higher risk of 
complications and worse radiation-related toxicity by two-
fold and this might cause more disruption in radiotherapy 
schedule, lower compliance in treatment and also higher 
rate of admission.(8) These would further impairs the 
patient’s likelihood to achieve the optimal nutritional 
intake that is recommended by The European Society for 
Clinical Nutrition and Metabolism (ESPEN) guideline for 
cancer.(6,9) ESPEN guideline for cancer recommended a 
minimum daily protein intake of 1.2 g/kg/day to maintain 
daily function, but as of today, there is no recommendation 
for protein quality.(9) Studies had shown a changes of 
certain biologic markers related to protein quality (10-12), 
thus whether to modify the quality of protein intake for 
cancer patients to gain benefit remained uncertain.
 Prognostic nutritional index (PNI), first coined by 
Onodera, et al., can be described as a nutritional and 
inflamation based index derived from serum albumin level 
and total lymphocyte count (TLC) calculation, of which 
the two had been used as a marker to determine nutritional 
status.(13-16) PNI is increasingly used in predicting the 
prognostic factors, such as survival, metastatic probability, 
and recurrence rate and chemotherapy adverse events in 
several cancer studies.(17-21) But no study had investigated 
the relation of PNI to quality of life. Quality of life, as one of 
the goal of cancer treatment, is related to nutritional status 
in cancer studies and can be assessed with various tools 
(22), but to our knowledge, there is no objective nutritional-
related markers that has been used to reflect the quality 
of life in cancer patients. As quality of life is associated 
with nutritional status, PNI might be able to be used as an 
objective, nutritional-related marker to reflect the quality 
of life of head and neck cancer patients. In this study, we 
attempted to investigate the correlation of PNI with quality 
of life, and also the correlation of quantity and quality of 
protein intake with PNI and quality of life.
Methods
This cross-sectional study took place at the Radiotherapy 
Department of dr. Cipto Mangunkusumo General Hospital, 
Jakarta for 4 months during April to July 2018. Estimation 
of sample size was calculated using the correlation study 
formula with α=0,05; β=0,20; r=0,353, resulting a minimum 
sample of 61 subjects. Head and neck cancer patients 
were consecutively recruited after initial screening with 
inclusion criteria of  a head and neck cancer diagnosis on 
every stadium, age 18-65 years old, currently undergoing 
radiotherapy treatment with or without concurrent 
chemotherapy of minimal 30-40 Gy dose and do not have 
any difficulties standing up. Exclusion criteria were patients 
having tuberculosis, human immunodeficiency virus (HIV) 
infection, kidney and liver disorder and also history of stroke 
and/or bone fracture that disabled them to stand up and do 
anthropometric measurement. A total of 61 patients were 
recruited and consented to sign an agreement form after 
throughout explanation and were able to be analyzed. This 
study was approved by Ethics Committee of the Faculty of 
Medicine, Universitas Indonesia with No. 0203/UN2.F1/
ETIK/2018.
 Patients were interviewed for obtaining the 
characteristic data with the help of medical record. Diet 
pattern for one month were also assessed by interviewing 
the patients using semi quantitative food frequency 
questionnaire (FFQ) method with the help of food models 
instrument. Patients were asked about the amount and 
frequency of their intake then recorded in structured FFQ 
form and were subsequently analyzed using Nutrisurvey 
2007 program to obtain the total calorie and protein intake 
per day. The quality of protein intake was also assessed 
by the ratio of animal protein to plant protein, with 50% 
animal protein as the cutoff for a good quality of protein 
intake. Anthropometric measurements that consisted of 
body weight and height were obtained using SECA® 
electrodigital scale and ShorrBoard® respectively. Body 
mass index (BMI)  was calculated by the result of weight 
and height measurements and was categorized into five 
groups by Asia Pacific criteria. Quality of life evaluation 
was done by using the standardized questionnaires from 
the European Organization for Research and Treatment 
of Cancer (EORTC). The questionnaires used were the 
EORTC Quality of Life Core Questionnaire (QLQ-C30) 
and Quality of Life Head and Neck module (QLQ-H&N35). 
It was developed for trials involving head and neck cancer 
patients and was reliable for use in Indonesia by a validation 
study. Data were calculated and then transformed into scores 
between 0-100 for each aspects of quality of life.
Laboratory Parameters
Laboratory data was obtained from one-time blood sample 
examination. Data consisted of serum albumin level and 
TLC. Serum albumin level was obtained using Hitachi 
917 analyzer with bromocresol green method. TLC was 
obtained  with  Sysmex®  hematology  autoanalyzer.  PNI 
was calculated using serum albumin and TLC, with PNI = 
(10 x serum albumin) + (0.005 x TLC).(13)
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Statistical Analysis
Data were cleaned, processed and analyzed using the 
Statistical Package for the Social Sciences (SPSS) software 
version 20.0. Kolmogorov-Smirnov test was used to 
determine the normality of data distribution with p>0.05 for 
normally distributed data. The correlation of protein intake 
with PNI, protein intake with quality of life and PNI with 
quality of life were all analyzed using Spearman Rank test.
Characteristic of subjects were described in Table 1. Mean 
age of subjects were 46.3±12.4 years old with the highest 
percentage of over 50 years old (45.9%). Males were more 
than females with a ratio of 3:1. Nasopharynx (57.4%) was 
the most common source of head and neck cancer in this 
study. Most subjects present with stage IV cancer (65.6%) 
and 73.8% of subjects had a combination of radiotherapy 
with concurrent chemotherapy.
 Mean BMI was 20.8±3.8 kg/m2 with around third of 
subjects were in low weight (32.8%). Assessment of dietary 
intake revealed that most of the patients (86.8%) were using 
oral route for nutritional intake and ate a median 30.9 (14.9-
67.9) kcal/kg/day of calories and 1.42 (0.26-4.11) g/kg/
day of protein. Eighty five point two percent subjects could 
achieve minimum recommended amount of 25 kcal/kg 
per day and 67.2% could achieve minimum recommended 
amount of 1.2 g/kg per day protein intake. Assessment of 
protein quality  revealed that 70.5% subjects protein intake 
consist of more than 50% animal protein source.
 Median of albumin was 4.2 (2.6-5.2) g/dL and mean of 
TLC was 640.1±335. Median of PNI was 45.9 (29.4-54.2). 
Quality of life were assessed using a scale method from 
the questionnaire which the patients had to choose from 
one to four and then calculated to determine the severity of 
symptoms or improvement in functions. The quality of life 
in patients were described in Table 2.
 This study showed no significant correlation between 
total protein intake, protein intake per body weight, and 
quality of protein intake with PNI (Table 3). A significant 
correlation were found in 7 symptom domains with total 
protein intake, that are pain (head and neck) (r=-0.32; 
p=0.01), swallowing (r=-0.37; p=0.004), social eating 
(r=-0.29; p=0.02), dry mouth (r=-0.41; p=0.001), sticky 
saliva (r=-0.32; p=0.01), fatigue (r=-0.28; p=0.03), nausea 
and vomiting (r=-0.26; p=0.04) and appetite loss (r=-0.3; 
p=0.01)  and in  2 symptom domain with protein intake 
per body weight that are dry mouth (r=-0.3; p=0.03) and 
Results
n (%)
46.3±12.4a
   18-29 5 (8.2)
   30-39 15 (24.6)
   40-49 13 (21.3)
   ≥50 28 (45.9)
   Male 47 (77.0)
   Female 14 (23.0)
   Nasopharynx 35 (57.4)
   Larynx 13 (21.3)
   Oral cavity 10 (16.4)
   Nasal cavity 3 (4.9)
   I 0 (0)
   II 2 (3.3)
   III 17 (27.9)
   IV 40 (65.6)
   Unknown 2 (3.3)
   Radiotherapy only 16 (26.2)
   Chemoradiotherapy 45 (73.8)
20.8±3.8a
   Underweight 20 (32.8)
   Normoweight 26 (42.6)
   Overweight 15 (24.6)
30.9 (14.9-67.8)b
   ≥ 25 kcal/kg/day 52 (85.2)
   < 25 kcal/kg/day 9 (14.8)
78.8 (11.6-242.9)b
1.42 (0.26-4.11)b
   ≥ 1.2 g/kg/day 41 (67.2)
   < 1.2 g/kg/day 20 (32.8)
   < 50% 18 (29.5)
   ≥ 50% 43 (70.5)
   Yes 8 (13.1)
   No 53 (86.8)
   Yes 0 (0)
   No 61 (100)
4.2 (2.6-5.2)b
640.1±335a
45.9 (29.4-54.2)bPNI
Categories of protein intake
Ratio of animal protein source
NGT usage
Parenteral usage
Serum albumin (g/dL)
TLC
BMI (kg/m2)
Nutritional status by BMI
Daily calorie intake (kkal/kgBB/day)
Categories of calorie intake
Daily total protein intake (g/day)
Protein intake per body weight (g/kgBB/day)
Variable
Age (years)
Gender
Cancer location
Stage
Treatment modality
Table 1. Characteristics of subjects (n=61).
aMean±standard deviation; bMedian (minimum- maximum).
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Score
Median (Min-Max)
Global health status 58.3 (0-100)
Physical function 66.7 (20-100)
Role function 66.7 (0-100)
Emotional function 75 (8.3-100)
Cognitive function 100 (16.7-100)
Social function 66.7 (0-100)
Fatigue 16.7 (0-66.7)
Nausea and vomiting 16.7 (0-66.7)
Pain 16.7 (0-66.7) 
Dyspnea 0 (0-50)
Insomnia 0 (0-100)
Appetite loss 33.3 (0-100)
Constipation 0 (0-100)
Diarrhea 0 (0-33.3)
Pain (head and neck) 25 (0-83.3)
Swallowing 41.6 (0-100)
Senses problem 50 (0-100)
Speech problem 44.4 (0-100)
Trouble with social eating 50 (0-100)
Teeth 0 (0-100)
Opening mouth 33.3 (0-100)
Dry mouth 66.7 (0-100)
Sticky saliva 66.7 (0-100)
Coughing 33.3 (0-100)
Felt ill 33.3 (0-100)
Quality of life by EORTC QLQ C-30
Quality of life by EORTC QLQ H&N35
Criteria
Table 2. Quality of life score by EORTC QLQ-C30 and 
EORTC QLQ-H&N35.
r p
Total protein intake 0.036 0.785
Protein intake per body weight -0.11 0.39
Quality of protein intake -0.088 0.5
Variable
Prognostic Nutritional Index 
Table 3. Correlation between protein intake and PNI.
appetite loss (r=-0.3; p=0.03)  but none was found in quality 
of protein intake (Table 4). This study also investigated the 
correlation between PNI and aspects of quality of life based 
on EORTC QLQ-C30 and EORTC QLQ-H&N35. There 
were significant correlation found between physical function 
(r=0.378; p=0.003), opening mouth (r=-0.325; p=0.011) 
and dyspnea (r=-0.257; p=0.045) with PNI. Several other 
symptom domains were also negatively correlated with 
PNI, althought not statistically significant (Table 5).
Discussion
were male.(7,23) Gupta, et al., who investigated the age-
standardized incidence rate (ASIR) in head and neck cancer 
patients in several regions showed a consistently higher rate 
of ASIR in males compared to females in most regions.(24) 
The most common risk factors for head and neck cancer 
were tobacco use and alcohol consumption, which were 
higher in male than female and these might be the reason 
of the higher incidence in males over the world.(25)  Most 
of other studies in America and Europe did not show that 
nasopharynx was the most common primary location, 
contrary to the result of this study.(25-27) But Rahmaeni, et 
al., who conducted a study in the other region of Indonesia, 
also had a similar findings.(23) Other study by Shield, et al., 
who investigated the proportional cases of lip, oral cavity, 
and pharyngeal cancer (LOCP) in various regions over the 
world showed a highest number of nasopharyngeal cancer 
in most Asian regions.(28) 
 Data for one month of calorie and protein intake 
were obtained from interview using semiquantitative FFQ 
structured form with trained investigator. The data showed 
that most subjects could achieve adequate minimum amount 
of calorie and protein intake, which are 25 kcal/kg/day and 
1.2 g/kg/day respectively according to ESPEN guideline.
(7) This result might be in association with subject’s BMI 
status, as in only third of the subjects were underweight. 
All of the subjects in present study were given pre-therapy 
nutritional education with a weekly routine follow-up by the 
general practitioners that were trained in clinical nutrition 
background. Nutritional education is recommended by 
ESPEN guideline as the first line of intervention in cancer 
treatment and has been linked with several favourable 
outcomes.(9) Usage of enteral route was lacking in this 
study, as only 13.1% subjects were using nasogastric tube 
during course of treatment. Currently, the use of enteral 
route is not the standard protocol in clinical pathway at 
the current institution althought there is proof that patients 
using nasogastric tube suffered less reduction in body 
weight compared to oral route.(29) We, therefore, suggest 
that the usage of enteral route to be a consideration in the 
future protocol to maximize outcomes.
The highest incidences of head and neck cancer in this study 
were found in subjects of more than 50 years old. This result 
was also shown in other studies, which most of the subjects 
74
Print ISSN: 2085-3297, Online ISSN: 2355-9179The Indonesian Biomedical Journal, Vol.11, No.1, April 2019, p.70-7
Ta
bl
e 
4.
 C
or
re
la
tio
n 
be
tw
ee
n 
pr
ot
ei
n 
in
ta
ke
 w
ith
 q
ua
lit
y 
of
 li
fe
 a
m
on
g 
he
ad
 a
nd
 n
ec
k 
ca
nc
er
 p
at
ie
nt
s.
G
lo
ba
l 
Q
oL
Ph
ys
ica
l 
Fc
R
ol
e 
Fc
Em
ot
io
na
l 
Fc
Co
gn
iti
ve
 
Fc
So
cia
l 
Fc
Fa
tig
ue
N
au
se
a 
an
d 
Vo
m
iti
ng
Pa
in
 
(G
lo
ba
l)
D
ys
pn
ea
In
so
m
ni
a
Ap
pe
tit
e 
Lo
ss
Co
ns
ti-
pa
tio
n
D
ia
rr
ho
ea
r=
0.
13
r=
0.
07
r=
-0
.2
r=
0.
2
r=
0.
07
r=
0.
24
r=
-0
.2
8
r=
-0
.2
6
r=
-0
.0
9
r=
-0
.0
3
r=
0.
03
r=
-0
.3
r=
-0
.0
8
r=
-0
.0
9
p
=0
.3
p
=0
.6
p
=0
.9
p
=0
.1
p
=0
.6
p
=0
.0
6
p
=0
.0
3
p
=0
.0
4
p
=0
.5
p
=0
.8
p
=0
.8
p
=0
.0
1
p
=0
.5
p
=0
.5
r=
0.
03
r=
-0
.0
8
r=
-0
.0
6
r=
0.
15
r=
0.
01
r=
0.
08
r=
-0
.2
r=
-0
.2
r=
-0
.0
7
r=
0.
1
r=
0.
12
r=
-0
.3
r=
-0
.0
4
r=
0.
00
3
p
=0
.8
p
=0
.5
p
=0
.7
p
=0
.3
p
=0
.9
p
=0
.5
p
=0
.1
p
=0
.1
p
=0
.6
p
=0
.4
p
=0
.3
p
=0
.0
3
p
=0
.7
p
=0
.1
r=
-0
.0
3
r=
0.
1
r=
0.
03
r=
-0
.0
5
r=
-0
.1
r=
-0
.0
4
r=
0.
2
r=
0.
02
r=
0.
19
r=
-0
.1
2
r=
0.
2
r=
0.
2
r=
0.
07
r=
-0
.0
3
p
=0
.8
p
=0
.9
p
=0
.8
p
=0
.7
p
=0
.4
p
=0
.8
p
=0
.1
p
=0
.9
p
=0
.1
5
p
=0
.3
p
=0
.1
p
=0
.1
p
=0
.6
p
=0
.8
To
ta
l p
ro
te
in 
int
ak
e
Pr
ot
ein
 in
ta
ke
 
pe
r b
od
y 
w
eig
hy
Q
ua
lity
 o
f p
ro
te
in  
int
ak
eVa
ria
bl
es
As
pe
ct
s o
f Q
ua
lit
y 
of
 L
ife
 (E
O
R
TC
 Q
LQ
-C
30
)
Pa
in
 (H
ea
d 
an
d 
N
ec
k)
Sw
al
lo
wi
ng
Se
ns
es
 
Pr
ob
le
m
Sp
ee
ch
 
Pr
ob
le
m
So
cia
l 
Ea
tin
g
Te
et
h
M
ou
th
 
O
pe
ni
ng
D
ry
 M
ou
th
St
ick
y 
Sa
liv
a
Co
ug
hi
ng
Fe
lt 
Ill
r=
-0
.3
2
r=
-0
.3
7
r=
-0
.1
5
r=
-0
.0
3
r=
-0
.2
9
r=
0.
01
3
r=
-0
.1
3
r=
-0
.4
1
r=
-0
.3
2
r=
0.
17
r=
0.
04
p
=0
.0
1
p
=0
.0
04
p
=0
.3
p
=0
.8
p
=0
.0
2
p
=0
.9
2
p
=0
.3
2
p
=0
.0
01
p
=0
.0
1
p
=0
.2
p
=0
.7
6
r=
-0
.1
7
r=
-0
.1
5
r=
-0
.6
4
r=
0.
17
r=
-0
.2
6
r=
0.
17
r=
0.
11
r=
-0
.3
r=
-0
.2
r=
0.
13
r=
0.
17
p
=0
.2
p
=0
.3
p
=0
.6
p
=0
.2
p
=0
.4
p
=0
.2
p
=0
.4
p
=0
.0
3
p
=0
.1
1
p
=0
.3
p
=0
.1
8
r=
0.
19
r=
0.
04
r=
0.
05
r=
0.
2
r=
0.
14
r=
0.
07
r=
0.
04
r=
0.
02
r=
0.
04
r=
0.
11
r=
0.
21
p
=0
.1
4
p
=0
.7
p
=0
.7
p
=0
.1
2
p
=0
.3
p
=0
.6
p
=0
.8
p
=0
.8
p
=0
.7
p
=0
.4
p
=0
.1
Va
ria
bl
es
As
pe
ct
s o
f Q
ua
lit
y 
of
 L
ife
 (E
O
R
TC
 Q
LQ
-H
&
N
35
)
To
ta
l p
ro
te
in 
int
ak
e
Pr
ot
ein
 in
ta
ke
 
pe
r b
od
y 
w
eig
hy
Q
ua
lity
 o
f p
ro
te
in 
int
ak
e
Gl
ob
al 
Qo
L
Ph
ys
ica
l 
Fc
Ro
le Fc
Em
ot
ion
al 
Fc
Co
gn
iti
ve
 
Fc
So
cia
l 
Fc
Fa
tig
ue
Na
us
ea
 an
d 
Vo
mi
tin
g
Pa
in 
(G
lob
al)
Dy
sp
ne
a
In
so
mn
ia
Ap
pe
tit
e 
Lo
ss
Co
ns
ti-
pa
tio
n
Di
ar
rh
oe
a
r=
0.1
r=
0.4
r=
0.1
4
r=
0.0
8
r=
0.1
5
r=
0.2
5
r=
0.0
2
r=
-0
.05
r=
-0
.15
r=
-0
.26
r=
-0
.17
r=
0.0
1
r=
-0
.14
r=
0.2
p=
0.4
p=
0.0
03
p=
0.3
p=
0.5
p=
0.2
p=
0.0
54
p=
0.9
p=
0.7
p=
0.2
p=
0.0
4
p=
0.2
p=
0.4
p=
0.3
p=
0.0
9
Va
ria
ble
s
As
pe
cts
 of
 qu
ali
ty
 of
 lif
e (
EO
RT
C 
QL
Q-
C3
0)
Pr
og
no
sti
c 
Nu
trit
ion
al 
Ind
ex
Pa
in 
(H
ea
d 
an
d N
ec
k)
Sw
all
ow
ing
Se
ns
es
 
Pr
ob
lem
Sp
ee
ch
 
Pr
ob
lem
So
cia
l 
Ea
tin
g
Te
et
h
M
ou
th
 
Op
en
ing
Dr
y M
ou
th
St
ick
y 
Sa
liv
a
Co
ug
hin
g
Fe
lt 
Ill
r=
-0
.7
r=
-0
.2
r=
-0
.05
r=
-0
.05
r=
0.0
8
r=
-0
.5
r=
-0
.32
r=
-0
.2
r=
-0
.2
r=
-0
.11
r=
0.4
p=
0.6
p=
0.2
p=
0.7
p=
0.7
p=
0.5
p=
0.7
p=
0.0
1
p=
0.8
p=
0.8
p=
0.4
p=
0.8
Va
ria
ble
s
As
pe
cts
 of
 Q
ua
lit
y o
f L
ife
 (E
OR
TC
 Q
LQ
-H
&
N3
5)
Pr
og
no
sti
c 
Nu
trit
ion
al 
Ind
ex
Ta
bl
e 
5.
 C
or
re
la
tio
n 
be
tw
ee
n 
PN
I w
ith
 q
ua
lit
y 
of
 li
fe
 a
m
on
g 
he
ad
 a
nd
 n
ec
k 
ca
nc
er
 p
at
ie
nt
s.
Q
oL
: q
ua
li
ty
 o
f 
li
fe
; F
c:
 f
un
ct
io
n.
Q
oL
: q
ua
li
ty
 o
f 
li
fe
; F
c:
 f
un
ct
io
n.
75
Protein and QoL in Head and Neck Cancer (Kelvianto A, et al.)Indones Biomed J. 2019; 11(1): 70-7DOI: 10.18585/inabj.v11i1.570
 Protein quality was one of the variables of interest 
in this study. Animal protein source contain varied amino 
acid that is relatively more fitting to human tissues 
utilization, specifically to several amino acids like cysteine, 
methionine, tryptophan, glycine and threonine.(30) Study 
showed a benefit for consumption of animal protein sources 
to muscle mass as it provided better retention and optimal 
muscle protein synthesis which also might be a benefit for 
cancer patients. The study also showed an inadequate intake 
of certain amino acids in elderly if the ratio of animal to 
plant protein was under 65%.(30) Other study by Gavelle, 
et al., that investigated the ratio of animal to plant protein 
by its relation to protein adequacy in French population 
showed that an inadequate protein intake along with amino 
acid lysine were present after the 50% ratio to higher plant 
protein onward.(31) The recommendation from Food 
and Agriculture Organization (FAO) is to use Digestible 
Indispensable Amino Acid Scores (DIAAS) to determine 
protein quality in each food source based on the limiting 
amino acid that can be digested and absorbed at ileum.(32) 
However, we cannot find the database to be used in our 
study so the DIAAS method remains unviable in present 
study.    
 To our knowledge, there are no current guidelines 
that include protein quality recommendation specifically 
in cancer patients, so we used the 50% ratio as our cut-off 
point for a good quality of protein intake based on the above 
mentioned study. But then, the difference in food tables used 
in Gavelle, et al., study, which primarily was for French 
food sources, and the food tables used in Indonesia might 
warrant a different result to be a matter of concern.(31)
 The result of PNI was derived from calculation of 
serum albumin level and TLC. Albumin had been used to 
determine the protein level in several studies and has been 
linked to prognosis of cancer patients, mainly survival rate.
(33,34) The variation in serum albumin level on various 
subjects might be the majority result of the inflammation 
process which would increase the level of proinflammatory 
markers, as it is consistently present in cancer patients. 
As a result, the proinflammatory markers would modulate 
the increment in acute phase proteins with a subsequent 
decrease in hepatic albumin synthesis.(35) 
 Thus, it was suggested that the adequate supply of 
amino acids that enhance serum albumin availability would 
be the matter of consideration. TLC was also decreased in 
almost all cancer patients receiving radiotherapy as it is one 
of the most sensitive to radiation especially to the area that 
is abundant in lymphoid tissues like the head and neck area.
(36,37) The radiation dose up to 50 Gy would significantly 
decrease the circulating lymphocyte.(36) Kuss, et al., found 
that the decreasing lymphocytes were of immunological 
importance.(37) In present study, PNI was meant to be a 
surrogate of both nutritional and immunological status so 
the changes in these two components resulted in variability 
in subjects and might have a better value if adequate calories 
and protein intake were warranted as in other nutritional 
status markers. This might also explain the result of this 
present study that most subjects could achieve adequate 
daily calorie and protein intake, so the variability of PNI 
might be minimal and not adequate to show a difference 
among subjects. Further studies should address this issue 
by doing several adjustments to have even more optimal 
results.
 Several aspects in quality of life were significantly 
correlated in this study to PNI and protein intake and mostly 
were from symptomatic aspects. This mentioned symptomps 
were thought to have an impact to patient’s eating process 
as they are in term to the oral mucositis that might possibly 
caused dysphagia and it might impact some of the calorie 
and protein intake that the subjects had.(38) Zahn, et al., 
showed less degree of oral mucositis with better calorie and 
protein intake and most probably resulted in better quality 
of life. That previous study also state that wound healing, 
which was one of the main problems in oral mucositis, 
would have better rate of healing if adequate intake was 
achieved by minimal of one week despite the patient’s 
current nutritional status.(26) The current recommendation 
for treatment of radiotherapy-induced oral mucositis were 
maintaining the oral hygiene and usage of pain medication.
(29) Thus, suggestion to also ensure optimal nutritional 
intake might confer a better outcome with a simple strategy 
like the nutritional education and a routine follow-up 
period. However, in this present study, we cannot fully 
affirm whether it was the oral mucositis first that caused the 
reduction of nutritional intake, PNI and quality of life or 
the low nutritional intake first that might be the cause of the 
worse oral mucositis, lower PNI and quality of life.  
 Domains of quality of life that is significantly 
correlated with PNI were physical function, open mouth 
and dyspnea. Study by Sayer, et al., that assessed hang-grip 
as a marker of physical function that is related to nutritional 
status to quality of life found that lower hand grip score is 
associated with lower quality of life especially in elderly. 
(39) In head and neck cancer patients that is suffering from 
dysphagia, silent aspiration is quite common and this is 
strongly related to pneumonia and death.(7) This might be 
the result of low immunity status that can be shown by low 
TLC and it happened to all of the subjects in this study as 
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a cause of decreased nutritional intake and the radiation. 
This might imply that PNI can predict the risk of having 
complication of aspiration and by increasing PNI would 
decrease the risk. 
 Although not significant, further analysis of the study 
also showed a consistent direction of correlation with either 
PNI and protein intake to the aspects of quality of life. 
This strongly suggest that the higher PNI would resulted 
in better functional status and less symptoms severity and 
might be enhanced by optimal protein intake even more. 
By this study, we could suggest that the usage of PNI to 
predict head and neck cancer patient’s quality of life is 
promising, however it needs more studies and evidence to 
be affirmed. Another suggestion would be using several 
follow-up periods of quality of life assessment as a serial 
investigations to look at the rate of reduction in quality of 
life as showed in previous study that most head and neck 
cancer patients would suffer for progressive reduction in 
quality of life along with radiation period.(40)
Conclusion
This present study showed a significant correlation between 
PNI and protein intake to several domains of quality of 
life which mostly were a symptomatic aspects. Optimizing 
daily protein intake might have a benefit in reducing 
toxicity-related symptoms in radiotherapy.  PNI remains 
the promising nutritional-based marker to be used to reflect 
quality of life although more evidence might be needed 
to ascertain this. We suggest that further studies should 
consider of prospective study design to investigate the 
severity of symptoms and functional status in a time-related 
manner, preferably with several follow-up periods.
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